Company Filing History:
Years Active: 2016-2018
Title: Abhijit Datta Khoje: Innovator in Pharmaceutical Compounds
Introduction
Abhijit Datta Khoje is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of MEK inhibitors. With a total of five patents to his name, Khoje's work is recognized for its potential impact on therapeutic treatments.
Latest Patents
Khoje's latest patents include innovative heterocyclyl compounds designed as MEK inhibitors. The first patent focuses on heteroaryl compounds of formula I, which are accompanied by their pharmaceutically acceptable salts and combinations with suitable medicaments. This patent also outlines the processes for preparing these compounds and their applications in treatment methods. The second patent similarly addresses heteroaryl compounds as MEK inhibitors, including their tautomers and pharmaceutically acceptable salts, along with the intended therapeutic uses.
Career Highlights
Khoje is currently employed at Lupin, Inc., a prominent player in the pharmaceutical industry. His work at Lupin has allowed him to explore and develop groundbreaking compounds that hold promise for various medical applications. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Some of Khoje's notable coworkers include Bhavesh Dave and Rakesh Kumar Banerjee. Their collaborative efforts contribute to the advancement of pharmaceutical research and development within their organization.
Conclusion
Abhijit Datta Khoje is a distinguished inventor whose work in developing MEK inhibitors showcases his commitment to advancing pharmaceutical science. His contributions are expected to have a lasting impact on therapeutic treatments in the medical field.